Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Coronary Disease × evolocumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Lung Cancer Metastatic 1 Hyperlipoproteinemia Type II 1 Glioma 1 Glioblastoma 1 Coronary Disease 1 Carcinoma, Non-Small-Cell Lung 1 Atherosclerosis 1

Interventions

evolocumab 1 Vitamin E 1 Risk Assessment 1 Progesterone 1 Methods 1 Estradiol 1 Electrocardiography 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03872401 2025-11-10

VESALIUS-CV

Amgen

Phase 3 Completed

12,301 enrolled

Coronary Disease, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡